Q&A: MDMA Strikes Optimistic Tone For Coming Year

Mark Leahey, who leads the Medical Device Manufacturers Association, says the group’s member companies are confident about the prospects of policy wins on key issues including the device tax, US FDA review and reimbursement under the Trump administration.

Exclusive interview Q&A KOI

It has been frenetic beginning of the Trump administration, with controversial and wide-reaching executive orders issued on a daily basis. But US device-industry groups have so far projected a calm and optimistic tone about prospects for the sector.

That is the certainly case for the Medical Device Manufacturers Association and its President and CEO Mark Leahey, who recently spoke to Medtech Insight about MDMA's priorities for 2017. The...

Permanent repeal of the device tax, which is currently under a two-year suspension, remains MDMA's top goal, and momentum is high toward achieving that as part of an Affordable Care...

More from Regulation

More from Policy & Regulation